Eyespot peek-a-boo: Leaf rolls enhance the antipredator effect of insect eyespots.

Animal colour patterns are often accompanied by specific, synergistic behaviours to most effectively defend prey against visual predators. Given the inherent context-dependence of colour perception, understanding how these colour-behaviour synergies function in a species' natural environment is crucial. For example, refuge-building species create a unique visual environment where most (or all) of the body is obscured unless closely inspected.

The effectiveness of eyespots and masquerade in protecting artificial prey across ontogenetic and seasonal shifts.

When constraints on antipredator coloration shift over the course of development, it can be advantageous for animals to adopt different color strategies for each life stage. Many caterpillars in the genus exhibit unique ontogenetic color sequences: for example, early instars that masquerade as bird feces, with later instars possessing eyespots. I hypothesize that larvae abandon feces masquerade in favor of eyespots due to ontogenetic changes in signaler size.

Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis.

Background: Adverse events identified during clinical trials can be important early indicators of drug safety, but complete and timely data on safety results have historically been difficult to access. The aim was to compare the availability, completeness, and concordance of safety results reported in ClinicalTrials.gov and peer-reviewed publications.

Uptake of F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study.

This study evaluated tracer uptake and lesion detectability with the novel radiopharmaceutical F-radiohybrid (rh)PSMA-7.3 in patients with prostate cancer (PCa). Ten patients (three with high-risk primary localized PCa [Cohort A], three with hormone-sensitive metastatic PCa [Cohort B], and four with castration-resistant metastatic PCa [Cohort C]) underwent whole-body F-rhPSMA-7.